NEW YORK, July 30 – Protein chip maker Zyomyx of Hayward, Calif., said Monday it had entered into an agreement for access to BD Biosciences' antibody collection.

Under the terms of the deal, Zyomyx will have access to BD Biosciences' antibodies for use in protein biochip development. BD Biosciences will also develop other antibodies exclusively for Zyomyx. 

Zyomyx did not disclose financial terms of the agreement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.